PR News WireThis post was originally published on this site
The addition of cardiology and neurology experts helps health companies scale evidence-based health products with confidence
AUSTIN, Texas, Sept. 25, 2025 /PRNewswire/ — MDisrupt announced today that it is onboarding professional members of the American Heart Association® to its expert marketplace, expanding access to cardiologists, neurologists, and multidisciplinary experts spanning clinical, regulatory, commercial, and operational domains in heart and brain health. This expansion builds on MDisrupt’s new platform launch and connects companies with a network of more than 3,000 vetted experts, helping healthtech and life science companies scale evidence-based solutions with confidence.
This collaboration with American Heart Association, which has invested in MDisrupt through American Heart Association Ventures™ and its venture incubator, Studio Red, enables companies to engage these experts for one-on-one consults, fractional roles, or full-time placements.
Cardiovascular and neurological diseases remain among the most urgent global health challenges. Cardiovascular disease causes an estimated 18 million deaths annually, while neurological disorders are the leading cause of disability worldwide (World Health Organization, 2023). By bringing American Heart Association professional members onto its platform, MDisrupt enables companies to embed frontline clinical perspectives into product development from the earliest stages, helping them de-risk solutions, meet regulatory standards, and accelerate adoption.
“At MDisrupt, our mission has always been to connect the brightest minds in healthcare with the innovators building the future. Welcoming American Heart Association professional members to our platform is a game-changer—not just for us, but for every company striving to create evidence-based solutions in heart and brain health,” said Ruby Gadelrab, Founder and CEO, MDisrupt. “By bringing world-class cardiology and neurology expertise directly into the innovation process, we’re helping companies move faster, with more confidence, and ultimately, improving health outcomes for millions.”
Research shows that without meaningful clinician involvement, healthtech innovations often fail to meet user needs or clinical workflows.1 Through the MDisrupt platform, health companies now gain access to this respected, deeply specialized expert community with real-world experience. Using MDisrupt’s AI-powered matching engine, clients can find the right American Heart Association professional members based on subspecialty and experience, then connect via real-time scheduling and secure, compliant workflows from introduction to engagement.
For experts, joining MDisrupt provides a new channel to share knowledge and shape innovation while being compensated for their contributions. Participants also have the option to donate a portion of their earnings to charitable causes, including the American Heart Association.
“This model reflects the future of how clinical expertise supports innovation—agile, transparent, and aligned with shared incentives to engage,” said Lisa Suennen, Managing Partner at American Heart Association Ventures. “MDisrupt helps us give Association members a unique opportunity to shape the next generation of healthcare solutions, and deliver on our mission to be a relentless force for a world of longer, healthier lives.”
With the addition of American Heart Association professional members, MDisrupt is broadening its expert network and redefining how critical health expertise drives evidence-based, cutting-edge innovation. By aligning leading specialists across medicine, science, regulation, and commercialization with healthtech pioneers, the company is advancing its vision of becoming the essential infrastructure for evidence-based health innovation.
About MDisrupt
MDisrupt is the health expert marketplace redefining how health innovation teams connect with real-world expertise. With a network of over 3,000 vetted professionals across clinical, regulatory, commercial, and reimbursement domains, the MDisrupt platform enables health companies to build safer, stronger, more evidence-backed solutions. Access experts by the hour, on demand, or for full-time roles all through a single, seamless experience. Learn more at mdisrupt.com.
About Studio Red
Studio Red creates and co-creates new companies to solve as-yet unsolved problems and market challenges in cardiovascular and brain health, and related conditions. We leverage the knowledge, assets and clinical acumen of the American Heart Association and its external scientific, clinical and entrepreneurial communities to drive new science-based solutions to commercial reality.
Studio Red is part of American Heart Association Ventures, the group that leads and coordinates the venture capital programs of the American Heart Association. Visit us at heart.org/ventures.
1 Lin, M.CM., Kim, TH., Kim, W.S. et al. Involvement of frontline clinicians in healthcare technology development: Lessons learned from a ventilator project. Health Technol. 12, 597–606 (2022)
SOURCE MDisrupt
